Log in to save to my catalogue

Use of hydroxyurea in French-speaking Sub-Saharan Africa

Use of hydroxyurea in French-speaking Sub-Saharan Africa

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11971222

Use of hydroxyurea in French-speaking Sub-Saharan Africa

About this item

Full title

Use of hydroxyurea in French-speaking Sub-Saharan Africa

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Annals of hematology, 2025-02, Vol.104 (2), p.937-941

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

The hydroxyurea is a save, affordable and essential medicine for sickle cell disease (SCD), reducing painful crises and mortality. To foster the prescription of hydroxyurea for patients with SCD in sub-Saharan African countries, the scientific advisory board of Drep.Afrique, a non-governmental organization dedicated to SCD in Africa, has developed...

Alternative Titles

Full title

Use of hydroxyurea in French-speaking Sub-Saharan Africa

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11971222

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11971222

Other Identifiers

ISSN

0939-5555,1432-0584

E-ISSN

1432-0584

DOI

10.1007/s00277-024-06180-2

How to access this item